![PDF) Memantine and Acetylcholinesterase Inhibitor Treatment in Cases of CDR 0.5 or Questionable Impairment PDF) Memantine and Acetylcholinesterase Inhibitor Treatment in Cases of CDR 0.5 or Questionable Impairment](https://i1.rgstatic.net/publication/24191718_Memantine_and_Acetylcholinesterase_Inhibitor_Treatment_in_Cases_of_CDR_05_or_Questionable_Impairment/links/54f5f0d70cf2ca5efefd73b9/largepreview.png)
PDF) Memantine and Acetylcholinesterase Inhibitor Treatment in Cases of CDR 0.5 or Questionable Impairment
![PDF] High-Dose Donepezil or Memantine: Next Step for Alzheimer's Disease? Larger Dosages May Benefit Patients Who Have 'Maxed Out' Existing Therapies | Semantic Scholar PDF] High-Dose Donepezil or Memantine: Next Step for Alzheimer's Disease? Larger Dosages May Benefit Patients Who Have 'Maxed Out' Existing Therapies | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b15d42c0bd4815bdf03544d13e163934bf0646c5/2-Table1-1.png)
PDF] High-Dose Donepezil or Memantine: Next Step for Alzheimer's Disease? Larger Dosages May Benefit Patients Who Have 'Maxed Out' Existing Therapies | Semantic Scholar
The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome
![Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists | SpringerLink Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-020-00789-3/MediaObjects/40263_2020_789_Fig1_HTML.png)